Literature DB >> 7794580

In situ hybridization shows increased endothelin-1 mRNA levels in endothelial cells of blood vessels of deoxycorticosterone acetate-salt hypertensive rats.

R Day1, R Larivière, E L Schiffrin.   

Abstract

Endothelin-1 is a potent vasoconstrictor peptide produced in blood vessels and other tissues that may play an important role in the control of local blood flow and could be involved in the pathogenesis of hypertension. Our previous studies have documented increases in endothelin-1 peptide content and gene expression in mesenteric arteries and thoracic aorta of deoxycorticosterone acetate (DOCA)-salt hypertensive rats. Although changes in endothelin-1 were observed in the blood vessels of hypertensive rats, the exact cellular sites of these changes were not identified clearly. In the present study we investigated endothelin-1 gene expression in DOCA-salt hypertensive rats by in situ hybridization histochemistry using a high specific activity 35S-labeled complementary RNA probe. Robust increases in endothelin-1 mRNA levels were observed in both mesenteric blood vessels and aorta of DOCA-salt hypertensive rats as compared with the vessels from the uninephrectomized control rats. In both cases it was shown clearly that these increased endothelin-1 mRNA levels only originated in the endothelial cell layer, not in the underlying smooth muscle cells. Higher expression levels of endothelin-1 mRNA by the endothelial cells of DOCA-salt hypertensive rats may play an important role in vascular hypertrophy and in the maintenance of elevated blood pressure in this and perhaps other models of experimental hypertension.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7794580     DOI: 10.1016/0895-7061(95)96213-4

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  5 in total

1.  Analysis of endothelin-1 and endothelin-1 receptor A gene polymorphisms in patients with pulmonary arterial hypertension.

Authors:  Paolo Calabrò; Giuseppe Limongelli; Valeria Maddaloni; Carmine Dario Vizza; Michele D'Alto; Raffaella D'Alessandro; Roberto Poscia; Paola Argiento; Brunella Ziello; Roberto Badagliacca; Emanuele Romeo; Giuseppe Pacileo; Maria Giovanna Russo; Francesco Fedele; Raffaele Calabrò
Journal:  Intern Emerg Med       Date:  2011-07-20       Impact factor: 3.397

2.  Influence of periostin-positive cell-specific Klf5 deletion on aortic thickening in DOCA-salt hypertensive mice.

Authors:  Hirofumi Zempo; Jun-Ichi Suzuki; Masahito Ogawa; Ryo Watanabe; Katsuhito Fujiu; Ichiro Manabe; Simon J Conway; Yoshiaki Taniyama; Ryuichi Morishita; Yasunobu Hirata; Mitsuaki Isobe; Ryozo Nagai
Journal:  Hypertens Res       Date:  2016-06-23       Impact factor: 3.872

3.  Antihypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats.

Authors:  E L Schiffrin; P Sventek; J S Li; A Turgeon; T Reudelhuber
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

4.  The DOCA-Salt Hypertensive Rat as a Model of Cardiovascular Oxidative and Inflammatory Stress.

Authors:  Abishek Iyer; Vincent Chan; Lindsay Brown
Journal:  Curr Cardiol Rev       Date:  2010-11

5.  Transgenic mice over-expressing ET-1 in the endothelial cells develop systemic hypertension with altered vascular reactivity.

Authors:  Justin Wai-Chung Leung; Wing Tak Wong; Hon Wai Koon; Fong Ming Mo; Sidney Tam; Yu Huang; Paul M Vanhoutte; Stephen Sum Man Chung; Sookja Kim Chung
Journal:  PLoS One       Date:  2011-11-11       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.